Degeneration of midbrain dopaminergic (DA) neurons is a key pathological event of Parkinson\u27s disease (PD). Limited adult dopaminergic neurogenesis has led to novel therapeutic strategies such as transplantation of dopaminergic precursors (DPs). However, this strategy is currently restrained by a lack of cell source, the tendency for the DPs to become a glial-restricted state, and the tumor formation after transplantation. Here, we demonstrate the direct conversion of mouse fibroblasts into induced DPs (iDPs) by ectopic expression of Brn2, Sox2 and Foxa2. Besides expression with neural progenitor markers and midbrain genes including Corin, Otx2 and Lmx1a, the iDPs were restricted to dopaminergic neuronal lineage upon differentiation. Aft...
Parkinson's disease is a common neurodegenerative disorder, which is due to the loss of dopaminergic...
Cell-based replacement therapy has great potential to improve the clinical outcome of Parkinson’s di...
Motor symptoms that define Parkinson’s disease (PD) are caused by the selective loss of nigral dopam...
Transplantation of dopaminergic precursors (DPs) is a promising therapeutic strategy of Parkinson’s ...
Transplantation of dopaminergic precursors (DPs) is a promising therapeutic strategy of Parkinson’s ...
Transplantation of dopaminergic precursors (DPs) is a promising therapeutic strategy of Parkinson’s ...
Transplantation of dopaminergic precursors (DPs) is a promising therapeutic strategy of Parkinson’s ...
In the last decade, direct reprogramming has emerged as a novel strategy to obtain mature and functi...
In the last decade, direct reprogramming has emerged as a novel strategy to obtain mature and functi...
Recent advances in somatic cell reprogramming have highlighted the plasticity of the somatic epigeno...
Parkinson's disease is a common neurodegenerative disorder, which is due to the loss of dopaminergic...
Parkinson\u27s disease, characterized by motor dysfunction due to the loss of nigrostriatal dopamine...
SummaryRecent advances in somatic cell reprogramming have highlighted the plasticity of the somatic ...
Parkinson's disease is a common neurodegenerative disorder, which is due to the loss of dopaminergic...
Cell-based replacement therapy has great potential to improve the clinical outcome of Parkinson’s di...
Parkinson's disease is a common neurodegenerative disorder, which is due to the loss of dopaminergic...
Cell-based replacement therapy has great potential to improve the clinical outcome of Parkinson’s di...
Motor symptoms that define Parkinson’s disease (PD) are caused by the selective loss of nigral dopam...
Transplantation of dopaminergic precursors (DPs) is a promising therapeutic strategy of Parkinson’s ...
Transplantation of dopaminergic precursors (DPs) is a promising therapeutic strategy of Parkinson’s ...
Transplantation of dopaminergic precursors (DPs) is a promising therapeutic strategy of Parkinson’s ...
Transplantation of dopaminergic precursors (DPs) is a promising therapeutic strategy of Parkinson’s ...
In the last decade, direct reprogramming has emerged as a novel strategy to obtain mature and functi...
In the last decade, direct reprogramming has emerged as a novel strategy to obtain mature and functi...
Recent advances in somatic cell reprogramming have highlighted the plasticity of the somatic epigeno...
Parkinson's disease is a common neurodegenerative disorder, which is due to the loss of dopaminergic...
Parkinson\u27s disease, characterized by motor dysfunction due to the loss of nigrostriatal dopamine...
SummaryRecent advances in somatic cell reprogramming have highlighted the plasticity of the somatic ...
Parkinson's disease is a common neurodegenerative disorder, which is due to the loss of dopaminergic...
Cell-based replacement therapy has great potential to improve the clinical outcome of Parkinson’s di...
Parkinson's disease is a common neurodegenerative disorder, which is due to the loss of dopaminergic...
Cell-based replacement therapy has great potential to improve the clinical outcome of Parkinson’s di...
Motor symptoms that define Parkinson’s disease (PD) are caused by the selective loss of nigral dopam...